Full Name
Tapas Mukherjee
Job Title
Post Doctoral Fellow
Company/Institution/ Organization
University of Toronto
Speaker Bio
Dr. Tapas Mukherjee (Ph.D.) is a POSTDOCTORAL FELLOW with Dr. Dana Philpott and Dr. Stephen Girardin in the Department of Immunology / Laboratory Medicine and Pathobiology, at the University of Toronto.
Tapas is trained as a microbiologist and as an immunologist. He completed his Ph.D. from the National Institute of Immunology, New Delhi, India. Tapas’s doctoral work has been instrumental in unravelling cell-intrinsic crosstalk between NF-kB signalling system in the context of health and disease.
Tapas’s research interests lie in understanding the aspects of host-pathogen interaction, cell-signalling networks and immuno-metabolism linked with human ailments. Currently, a part of his postdoctoral work focuses on elucidating the influence of Crohn’s disease (CD)-associated risk genes, NOD2 and ATG16L1 in disease pathogenesis. Particularly, Tapas aims to decipher the cellular and molecular basis of CD development and related extra-intestinal manifestations.
As a postdoctoral fellow, Tapas has been awarded (1) The American Association of Immunologists (AAI) Intersect Fellowship for Computational Scientists and Immunologists (2021-2022), (2) Canadian Institute of Health Research (CIHR) Postdoctoral Fellowship (2022-2024), and (3) “D. H. Gales Family Charitable Foundation Postdoctoral Fellowship” by the Banting & Best Diabetes Centre (BBDC-2022
Tapas is trained as a microbiologist and as an immunologist. He completed his Ph.D. from the National Institute of Immunology, New Delhi, India. Tapas’s doctoral work has been instrumental in unravelling cell-intrinsic crosstalk between NF-kB signalling system in the context of health and disease.
Tapas’s research interests lie in understanding the aspects of host-pathogen interaction, cell-signalling networks and immuno-metabolism linked with human ailments. Currently, a part of his postdoctoral work focuses on elucidating the influence of Crohn’s disease (CD)-associated risk genes, NOD2 and ATG16L1 in disease pathogenesis. Particularly, Tapas aims to decipher the cellular and molecular basis of CD development and related extra-intestinal manifestations.
As a postdoctoral fellow, Tapas has been awarded (1) The American Association of Immunologists (AAI) Intersect Fellowship for Computational Scientists and Immunologists (2021-2022), (2) Canadian Institute of Health Research (CIHR) Postdoctoral Fellowship (2022-2024), and (3) “D. H. Gales Family Charitable Foundation Postdoctoral Fellowship” by the Banting & Best Diabetes Centre (BBDC-2022
Speaking At
